Description
Glipdan-PG2 contains Metformin Hydrochloride 500mg, Glimepiride 2mg and Pioglitazone Hydrochloride 15mg, a triple-combination antidiabetic therapy indicated for the management of Type 2 diabetes mellitus, as prescribed by a healthcare professional.
Composition:
Metformin Hydrochloride 500mg + Glimepiride 2mg + Pioglitazone Hydrochloride 15mg
Pack Size:
10×10 Tablets
Packing:
Blister
Therapeutic Segment:
Diabetology | Cardio-Diabetic Care
Key Benefits:
• Helps improve glycaemic control in Type 2 diabetes mellitus
• Supports fasting and postprandial blood glucose management
• Triple-combination therapy with complementary mechanisms of action
• To be used only under medical supervision
• Convenient oral tablet formulation
Packaging:
10×10 Blister Pack




Reviews
There are no reviews yet.